PMC10196249_01
Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
fped-11-1179402-g001.jpg
PMC10196249_04_fped-11-1179402-g001.jpg
F1
Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
fped-11-1179402-g002.jpg
PMC10196249_04_fped-11-1179402-g002.jpg
F2
Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
PMC10196249_02
Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
fped-11-1179402-g001.jpg
PMC10196249_04_fped-11-1179402-g001.jpg
F1
Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
fped-11-1179402-g002.jpg
PMC10196249_04_fped-11-1179402-g002.jpg
F2
Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
PMC10196249_03
Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
fped-11-1179402-g001.jpg
PMC10196249_04_fped-11-1179402-g001.jpg
F1
Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
fped-11-1179402-g002.jpg
PMC10196249_04_fped-11-1179402-g002.jpg
F2
Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.
PMC10196249_04
Chest x-ray images of the four patients. (1) CASE 1: increased and blurred bilateral lung markings. (2) CASE 2: increased and blurred bilateral lung markings. (3) CASE 3: increased and blurred bilateral lung markings and patchy shadows on the right upper lung field. (4) CASE 4: increased and blurred bilateral lung markings.
fped-11-1179402-g001.jpg
PMC10196249_04_fped-11-1179402-g001.jpg
F1
Chest x-rays showed that bilateral lung markings increased and blurred (see Figure 1).
ALT level trend over time of the four patients. All patients had normal liver function at the initial stage of the course. ALT elevation (>41 U/L) occurred 5 to 8 days after the first onset of fever, then reached 3 to 10 folds of the upper range. All the patients received hepatoprotective therapy, and transaminase levels gradually decreased to the normal range after 2 to 3 weeks.
fped-11-1179402-g002.jpg
PMC10196249_04_fped-11-1179402-g002.jpg
F2
Table 2 and Figure 2). There was no evidence of infection for other pathogens related to liver injuries such as EBV, TORCH, ECHO virus, Coxsackie virus (CA16/CVB), and hepatitis B/C virus.